Assessment of the routine application of double modified nasopharyngeal airways versus the use of low-flow nasal cannula during pediatric upper gastrointestinal endoscopy.

Phase 1

• Conditions: Anaesthesia; Respiratory

• Registration Number: PACTR202205629173217
• Lead Sponsor: Mostafa Mansour Hussein

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-22
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

The study will enroll children of both sexes aged between 1 and 10 years old with an ASA physical status of I-II who will undergoing elective upper GI endoscopy under deep sedation.

Exclusion Criteria

Children will be excluded from the study if they have significant cardiovascular, hepatic, renal, or respiratory disorders. Patients with upper airway anatomical disorders, malignancy, known allergies to the drugs used, or who will require emergency procedures will be also excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The frequency of hypoxic events (SaO2 <90% for more than 15 seconds as identified by pulse oximetry or apnea for more than 15 seconds as identified by respiratory monitoring).

Secondary Outcome Measures

Name	Time	Method
Duration of endoscopy, gastroenterologist's satisfaction, incidence of nasopharyngeal injury caused by NPA insertion, bradycardia (heart rate <60 beats/min), hypotension (systolic blood pressure <20% from baseline), indication of endoscopy, and the occurrence of other side effects (e.g., nausea and vomiting).